相关数据集
MAT2A promotes reprogramming of the androgen response pathway in association with ERG and EZH2
To date there are very few tools to reverse the induced dedifferentiation program in CRPC and to improve the response to the androgen deprivation therapy. Here we report that MAT2A is an important onc
NIAID Data Ecosystem50
Incidence rate changes in prostate cancer treatment modality for non-metastatic disease stratified by NICE risk group between 2000–2005 and 2006–201.
Incidence rate changes in prostate cancer treatment modality for non-metastatic disease stratified by NICE risk group between 2000–2005 and 2006–201.
NIAID Data Ecosystem40
Prostate Cancer Therapeutics Market By Therapy (Hormone Therapy, Targeted Therapy, Chemotherapy, And Biologic Therapy), By Distribution Channel (Hospital Pharmacies, Online Sales, Retail Pharmacies, And Others), and By Region: Global Industry Perspective, Size, Trends, Comprehensive Analysis, And Forecast, 2024 – 2032
Global prostate cancer therapeutics market is expected to generate revenue of around USD 24.74 billion by 2032, growing at a CAGR of around 7.68% between 2024 and 2032.
www.zionmarketresearch.com2024-12-01 更新60
The current role of local treatment in metastatic prostate cancer: systematic review and meta-analysis
The aim of this study was to evaluate the current role of local treatment in prostate cancer with a low metastatic burden (or oligometastatic) in relation to survival and safety. We performed a meta-a
DataCite Commons2022-12-05 更新40
